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ABSTRACT:
In this study we show that diindolylmethane (DIM) induces autophagy in ovarian 
cancer cells by regulating endoplasmic reticulum (ER) stress and AMPK. Treatment 
of SKOV-3, OVCAR-3 and TOV-21G ovarian cancer cells with varying concentrations 
of DIM for 24 hours resulted in a concentration dependent induction of autophagy 
as measured by flowcytometry. Electron microscopy confirmed the presence of 
autophagosomes in DIM treated cells. Western blot analysis showed that DIM 
treatment increased the expression of LC3B, a hall mark of autophagy as well as p62 
and Atg 12 proteins that are accumulated during autophagy. Autophagy inhibitors 
bafilomycin or chloroquine inhibited DIM induced autophagy. Furthermore, DIM 
treatment significantly increased the expression of ER stress regulators such as 
Grp78, IRE1 and GADD153. Cycloheximide or ER stress inhibitor mithramycin not only 
blocked ER stress proteins that were activated by DIM but also autophagy. Silencing 
Grp78 or GADD 153 significantly blocked the expression of LC3B and p62 indicating 
that autophagy in our model is mediated by ER stress. Knocking out LC3B inhibited 
DIM induced autophagy. DIM treatment increased the cytosolic calcium levels which 
lead to the activation of AMPK in our model. Chelating cytosolic calcium with BAPT-
AM abrogated not only the phosphorylation of AMPK but also prevented DIM induced 
autophagy. Inhibiting AMPK by a chemical inhibitor or siRNA blocked the induction 
of LC3B or p62, indicating that DIM mediated autophagy requires activation of AMPK. 
Oral administration of DIM significantly suppressed SKOV-3 tumor xenografts in nude 
mice. Activation of ER stress and autophagy were observed in the tumors of DIM 
treated mice. Taken together, these results suggest that induction of autophagy 
by DIM in ovarian cancer cells was associated with ER stress and AMPK activation.
INTRODUCTION
Macroautophagy (autophagy hereafter) is a cellular 
mechanism which involves lysosome-dependent bulk 
degradation of cytoplasmic components to maintain 
homeostasis during starvation or stress conditions [1]. 
It is a highly conserved multi-step process regulated by 
several ‘Atg’ (Autophagy-related) genes [2]. Autophagic 
vesicles are formed through nucleation, assembly and 
elongation of small membrane structures forming double 
membrane autophagosome. Autophagosome nucleation 
requires a complex containing Atg6, whereas elongation 
of autophagosome involves Atg 12 and Atg 8 (LC3 
in mammals) [3]. All together, they form autophagic 
membrane. This membrane assembles around damaged 
organelles, proteins and cytoplasm, encapsulating the 
cargo which is degraded during the process of autophagy. 
Later, the outer membrane of autophagosomes is fused 
by endosomes or lysosomes to form autolysosomes 
where lysosomal hydrolases degrade the cytoplasm 
derived contents of autophagosome together with its inner 
membrane and presented to citric acid cycle for energy 
generation [4]. ER stress and activation of AMPK are 
among the major regulators of autophagy [5].Oncotarget 2012; 3:  435-449 436 www.impactjournals.com/oncotarget
Endoplasmic Reticulum (ER) or sarcoplasmic 
reticulum is an important cell organelle that is involved 
in  biosynthesis,  protein  folding  and  modification  of 
various soluble and insoluble proteins [6]. ER is also a 
store house of calcium and maintains its homeostasis 
[7]. ER is very sensitive to minor perturbations in its 
environment. Several physiological conditions such as 
glucose deprivation, oxidative stress and infection can 
lead to disturbances in the ER called ER stress [8]. ER 
stress leads to evolutionarily conserved cell stress reponse, 
Figure 1: DIM induces autophagy in ovarian cancer cells. A) SKOV-3, B) OVCAR-3, C) TOV-21G cells were treated with various 
concentrations of DIM for 24 hours. Representative dot plots and concentration dependent bar graphs of acridine orange fluorescence are 
shown. D) Electron microscopy images of control and DIM treated SKOV-3 cells. Means and SD of three independent experiments are 
shown. Student’s t-test was used for statistical analysis to compare control and DIM treatments. *p<0.05 when compared to control. 
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the unfolded protein response (UPR) which triggers two 
downstream signaling events. One is the induction of 
genes encoding for ER resident chaperones to properly 
fold the unfolded proteins and the other being suppression 
of initiation of protein synthesis [9]. These processes are 
carried out by three transmembrane ER stress sensors, 
RNA activated protein kinase like ER kinase (PERK), the 
basic leucine-zipper activating transcription factor ATF6, 
and  the  kinase  endoribonuclease  IRE1α  [9].    Several 
studies suggested that ER stress leads to autophagy [10]. 
Depending on the context, autophagy counterbalances 
ER stress induced ER expansion, enhances cell survival 
or commits the cell to non-apoptotic death. PERK, IRE1 
and increased cytosolic calcium have been implicated as 
mediators of ER stress induced autophagy in mammalian 
cells [9]. These mediators activate autophagy by 
upregulating Atg12 and LC3 conversion [11].
ER stress also leads to release of calcium from ER 
to cytosol, which in turn can activate various kinases that 
are involved in autophagy signaling [12, 13]. Calcium 
mediated autophagy is regulated by AMP activated protein 
kinase (AMPK), which senses cellular energy status to 
maintain homeostasis. It is usually activated when ATP 
levels are depleted in the cells. Increase in the cytosolic 
calcium leads to the activation of Ca2+/calmodulin 
activating  kinase  kinase  β  (CAMKKβ)  which  further 
activates AMPK [14]. AMPK stimulates autophagy by 
inhibiting mTORC1 at the level of TSC2 and Raptor. In 
addition, both AMPK and mTORC1 regulate autophagy 
through coordinated phoshphorylation of Ulk1 [15, 16]. 
Ovarian cancer is one of the leading gynecological 
cancers in United States with high mortality rates. It is 
usually detected in late stages with poor prognosis [17]. In 
our previous study, we showed that 3,3’-diindolylmethane 
(DIM) suppresses the growth of ovarian cancer cells 
in vitro  [18].  Here,  for  the  first  time  we  report  that 
DIM activates autophagy by inducing ER stress and 
phosphorylation of AMPK.
RESULTS
DIM induces autophagy in ovarian cancer cells
Autophagy is activated during stress conditions 
for degradation and recycling of macromolecules and 
organelles in the cell. We previously reported that DIM 
induces cellular stress leading to DNA damage in ovarian 
cancer cells [18]. Hence, we wanted to determine whether 
or not DIM induces autophagy in ovarian cancer cells.  The 
autophagy inducing effect of DIM was determined using 
acridine orange. Acridine orange is a lysomotropic agent 
that moves freely across biological membranes uncharged. 
Its protonated form accumulates in acidic compartments 
during autophagy, where it forms aggregates that 
fluoresces  bright  red  [19,  20]. Treatment  of  SKOV-3, 
OVCAR-3 or TOV-21G cells with various concentrations 
of DIM for 24 hours resulted in a concentration dependent 
Figure 2: DIM increases the expression of LC3B. A) 
SKOV-3, B) OVCAR-3 and C) TOV-21G cells treated with or 
without DIM. Representative blots show expression of Beclin1, 
Atg5, Atg12, P62 and LC3B. Actin was used as loading control
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increase in the number of autophagic cells (Fig 1 A-C). 
Our results showed that DIM-induced autophagy was 
nearly 3 to 6 fold in SKOV-3, 2 to 5 fold in OVCAR-3 and 
2 to 4 fold in TOV-21G cells, when compared with their 
respective controls (Fig 1 A-C). For example, 75µM DIM 
treatment for 24h induced autophagy in approximately 
30% in SKOV-3 cells, whereas it was 25% and 15% in 
OVCAR-3 and TOV-21G cells, respectively (Fig 1A-C). 
Autophagy induction was further confirmed by electron 
microscopy. Electron microscopy figures clearly shows 
autophagosome formation as depicted by accumulation of 
double membrane vesicles in SKOV3 cells treated with 
DIM (Fig 1D). 
Autophagy inducing effects of DIM were further 
Figure 3: Bafilomycin or chloroquine block DIM induced autophagy in ovarian cancer cells. Representative blots showing 
the expression of LC3B in SKOV-3 or OVCAR-3 cells that were exposed to A) 5µM chloroquine (i-ii) or B) 10 nM bafilomycin (i- ii) for 
two hours followed by treatment with DIM for 24 hours. Actin was used as loading control. Effect of DIM induced autophagy in presence 
of C) cloroquine (i, ii) or D) bafilomycin (i, ii) using flowcytometry. The experiments were repeated twice and similar results were obtained. 
The difference between all the groups was compared by ANOVA. *p<0.05 when compared to control.
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confirmed by western blot analysis. SKOV-3, OVCAR-3 
or TOV-21G cells were exposed to various concentrations 
of DIM for 24 hours. Our results reveal that DIM 
upregulates LC3B in a concentration dependent manner 
in all the cell lines tested (Fig 2 A-C). Our quantitation 
results showed approximately 2 to 5 fold increase in the 
expression of LC3B by DIM treatment in different cell 
lines. DIM induced autophagy was accompanied by 
increase in the accumulation of Atg12 and p62 (Fig 2 
A-C). Autophagy marker p62 is a protein that is selectively 
incorporated into the autophagosome by directly binding 
to LC3B and hence aggregate during autophagy [21]. On 
Figure 4: DIM induces ER stress in ovarian cancer cells: A) Representative blots showing the concentration dependent 
effect of DIM on Grp78, IRE1 and GADD153 in i) SKOV-3, ii) OVCAR-3 and iii) TOV-21G cells. B) SKOV-3 (i) or 
OVCAR-3 (ii) cells were treated with 10µg/ml cycloheximide followed by 75µM DIM for 24 hours. Whole cell lysates were analyzed by 
western blotting for the expression of Grp78, IRE1 and GADD153. C) Effect of 100nM mithramycin on DIM induced expression of Grp78, 
IRE1 and GADD153 in i) SKOV-3 or ii) OVCAR-3 is shown. Actin was used as a loading control. 
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the other hand, Atg12 is instrumental in the autophagic 
vesicle biogenesis [3]. DIM treatment failed to exert any 
effect on Beclin 1 or Atg5 in either of the cell lines tested.   
DIM  increases  autophagic  flux  confirming 
autophagy induction 
LC3B is the hallmark of autophagy, however its 
expression not always means induction of autophagy. 
Expression of LC3B  may represent either the 
increased generation of autophagosomes or a block in 
autophagosomal maturation [22]. For example, agents that 
impair lysosomal acidification such as chloroquine and 
bafilomycin A1 leads to accumulation of LC3B even under 
normal conditions because turnover of LC3B by basal 
autophagy is blocked. Hence, one cannot differentiate 
between induction of autophagy and impairment of 
autophagolysosomal maturation simply by measuring 
levels of LC3B. Hence, it is important to determine 
autophagic flux using LC3 turnover assay in presence and 
absence of chloroquine or bafilomycin A1. Ideally, when 
Figure 5: ER stress regulates DIM induced autophagy. A) Representative blots showing the expression of Atg12, p62 or LC3B in 
i) SKOV-3 or ii) OVCAR-3 cells treated with or without DIM in presence of mithramycin. Effect of DIM in presence and absence of CHX 
in iii) SKOV-3 cells were also represented.  Silencing of B) Grp78, C) GADD 153 or D) LC3B using respective siRNA’s in SKOV-3 cells 
for 48 hours and treated with or without 75 µM DIM for 24 hours. Whole cell lysates were analyzed by western blotting for the expression 
of Grp78, IRE1, GADD 153, Atg12, P62 or LC3B. Actin was used as a loading control.
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the cells are treated with lysosomotropic agents such as 
chloroquine or bafilomycin A1, the degradation of LC3B 
is blocked, resulting in the accumulation of LC3B [23]. 
Under these conditions, the difference in LC3B levels in 
the presence and absence of chloroquine or bafilomycin 
A1 is more under autophagy induced conditions, 
indicating that autophagic flux is increased [24]. 
Hence,  to  measure  the  autophagic  flux  induced 
by DIM, SKOV-3 or OVCAR-3 cells were exposed 
to  chloroquine  or  bafilomycin  for  one  hour  followed 
by treatment with DIM for 24 hours. As expected, 
bafilomycin or chloroquine treatment alone increased the 
accumulation of LC3B indicating the blockade of LC3B 
degradation (Fig 3A-B). The expression of LC3B induced 
by combination of DIM with bafilomycin or chloroquine 
was higher compared to the expression of LC3B induced 
Figure 6: AMPK activation by DIM is necessary for DIM induced autophagy.  A) Effect of various concentrations of DIM on 
p-AMPK (Ser 217) in i) SKOV-3, ii) OVCAR-3 or iii) TOV-21G cells. B) Representative blots of p-AMPK, Atg12, P62 or LC3B treated 
with 75µM DIM in presence or absence of 20µM Compound C in i) SKOV-3 or ii) OVCAR-3 cells. C) Silencing of AMPK using AMPK 
siRNA in SKOV-3 cells and treated with DIM for 24 hours. Whole cell lysates were analyzed by western blotting for the expression of 
p-AMPK, P62 and LC3B. Actin was used as a loading control.
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by DIM or lysosomal inhibitor treatments alone indicating 
that autophagic flux was increased in presence of DIM, yet 
again confirming that autophagy is induced in our model. 
Furthermore, acridine orange assay in presence 
of  chloroquine  or  bafilomycin  was  performed  to 
ensure the inhibition of autophagosomal maturation. 
Since,  chloroquine  or  bafilomycin  inhibits  lysosomal 
acidification, acridine orange staining induced by DIM 
was drastically reduced in presence of these inhibitors 
(Fig 3C-D). Our results established that bafilomycin or 
chloroquine treatment blocked DIM induced acridine 
orange staining in SKOV-3 and OVCAR-3 cells. 
DIM induces ER stress in ovarian cancer cells
Our next step was to investigate the molecular 
mechanism behind DIM induced autophagy. Recent 
literature suggests that disturbances in the integrity of ER 
activate autophagy [6]. Hence, we questioned ourselves 
whether DIM causes ER stress in ovarian cancer. To 
address this issue, SKOV-3, OVCAR-3 or TOV-21G cells 
treated with varying concentrations of DIM were subjected 
to western blotting. Our results clearly demonstrate that 
DIM substantially induces the expression of Grp78 in a 
concentration dependent manner in all the three cancer cell 
lines (Fig 4A i-iii). Accumulation of Grp78 is an indicator 
of ER stress. Our results further show that DIM induced 
ER stress was accompanied by the accumulation of GADD 
153 and IRE1 in SKOV-3, OVCAR-3 and TOV-21G 
cell lines (Fig 4A i-iii). Both GADD 153 and IRE1 are 
regulated by Grp78 during ER stress. These observations 
indicate that DIM induces ER stress in ovarian cancer 
cells. 
Cycloheximide, a protein synthesis inhibitor or 
Mithramycin, an ER stress inhibitor block DIM 
mediated ER stress
Because  we  observed  significantly  enhanced 
protein expression of Grp78, GADD 153 and IRE1 by 
DIM treatment leading to unfolded protein response 
(UPR), we wanted to determine whether blocking protein 
induction would inhibit expression of Grp78, GADD 153 
or IRE1. To do that, we used cycloheximide (CHX), a 
protein synthesis inhibitor. SKOV-3 or OVCAR-3 cells 
were treated with 10µg/ml CHX for 2 hours followed by 
treatment with 75µM DIM for 24 hours. Our data reveals 
that the drastic increase in the expression of Grp78, 
GADD 153 and IRE1 induced by DIM was attenuated in 
presence of CHX treatment in SKOV-3 and OVCAR-3 
cells (Fig 4B). 
CHX is a general protein synthesis inhibitor. To 
confirm that ER stress is induced in our model, we used 
mithramycin, a specific ER stress inhibitor. Mithramycin 
is a gene selective sp1 inhibitor that blocks transcription 
and protein synthesis of ER chaperones [25].
As shown in Figure 4C, mithramycin treatment 
blocked the induction of Grp 78, IRE1α and GADD 153. 
These results strongly support that DIM activates ER 
stress in ovarian cancer cells. 
Blocking  ER  stress  inhibits  DIM  induced 
autophagy
Literature suggests that disturbances in ER 
homeostasis lead to autophagy. Since we observed that 
ovarian cancer cells exposed to DIM undergo both ER 
stress and autophagy, we hypothesized that DIM activates 
autophagy in ovarian cancer cells by inducing ER stress. 
To establish that ER stress induced by DIM leads to 
formation of autophagic vesicles, we exposed ovarian 
cancer cells to mithramycin or CHX before treating cells 
with DIM. Our results show that mithramycin or CHX 
treatment not only blocked the enormous increase in 
the expression of LC3B associated with DIM, but also 
abrogated the significant upregulation of p62 and Atg12 
(Fig 5A i-iii). These results support our hypothesis that 
ER stress was involved in the regulation of DIM mediated 
autophagy in ovarian cancer cells.
Silencing of Grp78, GADD 153 or LC3B inhibits 
DIM induced autophagy
Both Mithramycin and CHX treatment blocked 
induction of several molecules that regulate ER stress 
and autophagy. However, chemical inhibitors are known 
to be associated with off-target effects. Therefore, to 
firmly establish the role of ER stress in DIM mediated 
autophagy, we sought to determine the effects of DIM 
in SKOV-3 cells in which Grp78 and GADD 153 were 
transiently silenced using respective siRNA’s. SKOV-
3  ovarian  cancer  cells  were  transfected  with  specific 
siRNA’s followed by treatment with DIM. Fig 5B shows 
that silencing Grp78 not only abrogated the induction 
of its downstream molecules IRE1 and GADD 153, but 
also blocked the DIM induced LC3B, p62 and Atg12. 
These results indicate that induction of ER stress not only 
regulates UPR as indicated by expression of IRE1 and 
GADD 153, but also controls autophagy as evident by the 
expression of LC3B, p62 and Atg12.
Because silencing Grp78 blocked DIM induced 
expression of GADD 153, we wanted to evaluate the effect 
of DIM on SKOV-3 cells after silencing GADD 153. 
Similar to our Grp78 data, silencing GADD 153 in ovarian 
cancer cells blocked DIM induced up regulation of LC3B, 
p62 and Atg12 (Fig 5C). These results confirmed that 
DIM-induced autophagy was mediated by the activation 
of ER stress in ovarian cancer cells. 
To gain further insight into this mechanism, we 
silenced LC3B using its specific siRNA. Fig 5D shows Oncotarget 2012; 3:  435-449 443 www.impactjournals.com/oncotarget
that silencing LC3B not only blocked DIM induced 
expression of LC3B, but also p62 and Atg12 which were 
associated with autophagy. These results indicate that 
LC3B was required for the induction of p62 and hence 
autophagy. 
DIM regulates autophagy by activation of AMPK
Several recent studies showed that activation of 
AMPK is important in regulating autophagy. We wanted 
to know whether this was the case in our model. Our 
western blotting showed that DIM activated AMPK by 
phosphorylating it at Thr-172 in SKOV-3, OVCAR-3 and 
TOV-21G ovarian cancer cells (Fig 6A i-iii). To confirm 
the role of AMPK in DIM induced autophagy, we exposed 
the cells to compound C, a chemical inhibitor of AMPK 
before treating with DIM. Our results from Fig 6B shows 
that treating SKOV-3 or OVCAR-3 cells to compound C 
inhibited DIM-induced activation of AMPK (Fig6B i-ii). 
Interestingly, blocking AMPK activation also blocked 
Figure 7: Increase in the cytosolic calcium plays a crucial role in DIM induced autophagy. A) SKOV-3 (i), OVCAR-3 (ii) or 
TOV-21G (iii) cells were loaded with Fluo-3AM dye. Using a flowcytometer, base line reading was taken for a minute. Immediately, cells 
were exposed to 75 µM DIM for a minute followed by treatment with EGTA for another minute. Increase in the FL-1 intensity is related 
to increase in the cytosolic calcium levels. B) SKOV-3 (i) or OVCAR-3 (ii) cells were treated with BAPT-AM for one hour followed by 
treatment with 75µM DIM for 4 hours. Whole cell lysates were analyzed for western blotting for p-AMPK (Ser 217), Atg12 and LC3B. 
Actin was used as a loading control.
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Figure 8: DIM suppresses the growth of ovarian tumors in nude mice by inducing ER stress modulated autophagy. 
SKOV-3 tumor cells were implanted into athymic nude mice. Mice received 2mg/day DIM by oral gavage every day. A) Effect of DIM on 
ovarian tumor growth. *p<0.05 when compared to control. B) Animal weights during the course of the experiment. C) Expression of ER 
stress or autophagy molecules in the tumors of mice administered with DIM. Tumors from control and treated mice were excised on day 42 
after implantation. Lysates from different tumors were loaded in different lanes and analyzed by western blotting for Grp78, IRE1, GADD 
153, Atg12, P62 and LC3B. Blots were stripped and reprobed with actin antibody to verify equal protein loading. 
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the expression of LC3B, p62 and Atg 12 in SKOV-3 and 
OVCAR-3 cells, indicating that AMPK also mediates the 
effect of DIM on autophagy (Fig 6B i-ii).
To further confirm the role of AMPK, we silenced 
AMPK  by  using  specific  siRNA  against  AMPK. 
Genetically silencing AMPK not only inhibited 
the activation of AMPK by DIM by blocking its 
phosphorylation at Thr 172, but also abrogated DIM 
induced expression of LC3B and p62 (Fig 6C). Taken 
together, these results strongly establish that AMPK is 
a major regulator of DIM induced autophagy in ovarian 
cancer cells. 
DIM elevates cytosolic calcium to regulate AMPK 
and autophagy
We wanted to gain further insight into how DIM 
caused activation of AMPK. Many studies suggested that 
increase in the cytosolic calcium leads to activation of 
AMPK. It is well known that endoplasmic reticulum is 
the store house of calcium. Perturbation in the ER results 
in the release of calcium into cytosol thereby causing 
deregulation of calcium homeostasis leading to activation 
of AMPK and autophagy. To test whether DIM treatment 
leads to the release of calcium in ovarian cancer cells, we 
loaded cells with Fluo-3AM and continuously monitored 
calcium levels using Accuri C6 flow cytometer. Baseline 
reading was taken for a minute, followed by exposure of 
cells to DIM. Figure 7A clearly demonstrates an increase 
in the intensity of the baseline after DIM treatment 
suggesting the release of calcium in different ovarian 
cancer cells.
To test whether increase in the cytosolic calcium 
leads to activation of AMPK, we treated SKOV-3 or 
OVCAR-3 cells with BAPT-AM, a calcium chelater 
followed by exposure to DIM for 4 hours. We observed 
that BAPT-AM significantly blocked the activation of 
AMPK (Fig 7B i-ii). Furthermore, the expression of 
LC3B or Atg12 induced by DIM was also significantly 
suppressed by BAPT-AM treatment (Fig 7B i-ii). Taken 
together, these results suggest that increase in the cytosolic 
calcium regulates autophagy in DIM treated ovarian 
cancer cells.
Tumor growth suppression by DIM is associated 
with ER stress and autophagy
We previously demonstrated that DIM inhibits 
the growth of various ovarian cancer cells in vitro 
[18]. Whether or not, DIM suppresses the growth of 
ovarian tumors in vivo was not clear. Hence, we used 
ovarian tumor xenograft model to determine the growth 
suppressive effects of DIM in vivo.  We injected 5 x 106 
SKOV-3 cells subcutaneously on both right and left flanks 
of female athymic nude mice. Mice were randomized into 
two groups of 10 mice each. Treated group received 2mg/
day DIM by oral gavage, whereas, control group received 
PBS. Tumor volume was recorded thrice a week using 
vernier calipers and weight of mice was recorded twice a 
week. Our results show that DIM significantly suppressed 
the growth of ovarian tumors. For example, at day 42, 
average tumor volume in the group of mice that received 
DIM was approximately 100 mm3 which was remarkably 
lesser as compared to the average tumor volume of 250 
mm3 in control group (Fig 8A). Interestingly, weight 
of  mice  from  both  groups  did  not  differ  significantly 
suggesting that DIM was not toxic to the mice (Fig 8B). 
To test whether DIM mediated tumor growth suppression 
was associated with ER stress and autophagy, tumors from 
control and DIM treated mice were lysed and subjected 
to western blotting. As expected, our results show that 
DIM activates ER stress and autophagy in vivo. We 
observed an increase in several ER stress markers such 
as Grp78, GADD 153 and IRE1 in the tumors of DIM 
treated mice as compared to controls (Fig 8C). Moreover, 
we observed an increase in the phosphorylation of AMPK 
and expression of other autophagy markers such as LC3B 
and p62 in DIM treated tumors (Fig 8C). These results 
suggest that DIM suppressed the growth of ovarian tumors 
in vivo by inducing ER stress mediated autophagy. 
DISCUSSION
Our study for the first time demonstrates that DIM 
treatment induces autophagy in ovarian tumor cells in vitro 
and in vivo by enhancing ER stress and activating AMPK. 
Autophagy is a catabolic process during which damaged 
organelles and proteins are engulfed and degraded to 
provide metabolic needs. Autophagy is activated in 
response to various kinds of stress. Our published studies 
showed that DIM induces cellular stress in ovarian cancer 
cells [18]. Our current results suggest that DIM induces 
autophagy in SKOV-3, OVCAR-3 and TOV-21G human 
ovarian cancer cells in a concentration dependent manner 
as analyzed by flowcytometry and electron microscopy. 
LC3B is accumulated and localized to vesicular 
structures during autophagy and hence it is considered as 
a hallmark of autophagy. Activation of autophagy by DIM 
in our model was confirmed by enhanced expression of 
LC3B. Our results also showed that autophagy induction 
was associated with an increase in the expression of p62 
and Atg12. Autophagy marker p62 is a protein that is 
selectively incorporated into autophagosome by directly 
binding to LC3B and hence aggregate during autophagy. 
Atg12 is instrumental in the autophagic vesicle biogenesis 
[3]. Our studies are in agreement with previous studies, 
which show that agents such as resveratrol induce 
autophagy by increasing the expression of LC3B [21]. 
Beclin 1 and Atg5 are genes that are responsible for 
initiation of autophagy. However, to our surprise, Beclin1 
or Atg5 expression by DIM treatment was not significantly Oncotarget 2012; 3:  435-449 446 www.impactjournals.com/oncotarget
altered. It is interesting to note that several studies have 
reported that induction of autophagy can be independent 
of Beclin 1 or Atg5 [26, 27]. 
DIM  treatment  in  presence  of  bafilomycin  or 
chloroquine lead to increased expression of LC3B 
when compared to the cells treated either with DIM or 
inhibitors alone, suggesting increased autophagic flux. 
Both  bafilomycin  and  chloroquine  inhibit  the  fusion 
between autophagosomes and lysosomes, thus prevent 
the execution step of autophagy. Nonetheless, our results 
from  flowcytometry  demonstrated  that  chloroquine  or 
bafilomycin completely blocked DIM-induced autophagy. 
Induction of autophagy in ovarian cancer cells was 
confirmed by genetic silencing of LC3B. Knocking out 
LC3B inhibited DIM induced expression of LC3B as well 
as Atg12 and p62. Our observations are in agreement with 
several studies demonstrating the role of LC3B and p62 in 
autophagy [21, 28].
Our study established that autophagy induced by 
DIM treatment was mediated by activation of ER stress 
or AMPK activation. Activation of ER stress in our model 
was associated with an increase in the expression of 
Grp78, IRE1 and GADD153. Grp78 is a chaperone that 
folds protein into its proper confirmation. Grp78 acts as a 
sensor in ER and it binds to IRE1 under normal conditions 
[9]. However, during ER stress, it releases IRE1, which 
further leads to expression of a transcriptional factor 
GADD 153 that continues the response of unfolded 
proteins [5, 9]. Both IRE1 and GADD 153 were 
significantly up regulated by DIM treatment in all the 
three ovarian cancer cells. Genetically silencing Grp78 
attenuated DIM induced expression of IRE1 and GADD 
153, suggesting the importance of Grp78 in regulating 
DIM induced ER stress.
 Furthermore, role of ER stress by DIM 
induced autophagy was established in our model. 
Pharmacologically inhibiting ER stress using chemical 
inhibitors such as cycloheximide or mithramycin not 
only blocked the induction of Grp78, IRE1 or GADD 
153, but also inhibited DIM induced expression of Atg12, 
LC3B and p62 in SKOV-3 and OVCAR-3 ovarian cancer 
cells. ER stress is connected to autophagy in our model 
by IRE-1 and GADD153. IRE1 activates transcriptional 
factors such as Hac1 which is capable of inducing several 
Atg genes leading to the induction of autophagy [5, 11, 
29]. Accordingly, our results showed that blocking the 
expression of IRE1 inhibited DIM induced autophagy. 
During ER stress, Grp78 releases IRE1 leading to 
the expression of GADD 153. Several studies have 
demonstrated the involvement of GADD 153 in autophagy 
[30]. Knocking out Grp78 or GADD 153 blocked the 
expression of LC3B, Atg12 and p62 induced by DIM. 
Interestingly knock down of Grp78 also abrogated DIM 
induced expression of IRE1 and GADD 153, confirming 
that IRE-1 and GADD 153 are major players of ER stress 
and regulate autophagy in our model. Similar to our 
observations, ER stress induced autophagy was observed 
by capsaicin and atorvastatin in other malignancies [31, 
32].
ER stress not only activates UPR, but also leads to 
the release of calcium from ER into cytosol. Our studies 
demonstrated that DIM treatment elevates cytosolic 
calcium levels in ovarian cancer cells. Cytosolic calcium 
levels were reduced in the presence of EGTA, a calcium 
chelater. Release of calcium into cytosol leads to the 
activation of various kinases including AMPK which is 
known to regulate autophagy. AMPK is also an energy 
sensor and is activated when there is increase in AMP/
ATP ratio, which is usually the scenario during cellular 
stress, the same reason for which autophagy is activated. 
In agreement with these facts, DIM treatment activated 
AMPK in all the three ovarian cancer cell lines. BAPT-
AM, a calcium chelater not only suppressed DIM induced 
phosphorylation of AMPK but also attenuated the 
expression of LC3B and Atg12. Role of AMPK in DIM 
induced autophagy was established by silencing AMPK. 
These studies showed that absence of AMPK inhibits 
the expression of p62 or LC3B, the classic markers 
of  autophagy,  hence  confirming  that AMPK  regulates 
autophagy in our model. All these observations are in 
agreement with several studies showing that activation of 
AMPK leads to autophagy [16, 32].
Oral administration of 2mg DIM everyday 
substantially suppressed the growth of ovarian tumors. 
The tumors from DIM treated mice clearly demonstrated 
the  significant  induction  of  ER  stress  and  autophagy 
similar to our in vitro observations. Interestingly, mice that 
received DIM did not show any significant change in the 
body weight when compared with the weight of control 
mice. DIM is an indole compound present in cruciferous 
vegetables [33]. Recent clinical trials suggested that 
DIM is well tolerated in humans [34, 35]. Interestingly, 
administration of 2mg/kg/day DIM through oral route 
suppressed Cervical Intraepithelial Neoplasia with 1-2 
grades [34]. Several pharmacokinetic studies on DIM 
stated that up to 300mg single dose of DIM can be well 
tolerated in humans [35]. Our dose of DIM falls within 
the accepted and tolerated dose in humans. Nevertheless, 
further clinical studies are needed to show that DIM can 
reduce the ovarian tumor growth in humans.
In conclusion, DIM promotes autophagy in ovarian 
cancer through activation of ER stress and AMPK. To our 
knowledge, this is the first report showing the regulation 
of autophagy by DIM in ovarian cancer cells.
MATERIALS AND METHODS
Chemicals
BR-DIM was a kind gift from Dr. Michael Zeligs 
(Bio Response, Boulder, CO).  Antibodies against 
Atg5, Beclin, LC3B, Atg12, GADD 153, Grp78, IRE-Oncotarget 2012; 3:  435-449 447 www.impactjournals.com/oncotarget
1α, p-AMPK including AMPK and LC3B siRNA were 
obtained from Cell Signaling Technology (Danvers, 
MA). Antibody against p62 was obtained from Abcam 
Inc  (Cambridge,  MA).  Actin  antibody,  bafilomycin, 
cycloheximide, chloroquine, mithramycin, compound C, 
EGTA, acridine orange and Medium 199 were procured 
from Sigma Aldrich (St. Louis, MO). RPMI and McCOY 
5A were purchased from Mediatech (Manassas, VA). 
Grp78 siRNA was from Santa Cruz (Santa Cruz, CA). 
GADD 153 siRNA was from Thermo Scientific (Lafayette, 
CO). Fluo-3AM was from Invitrogen (Carlsbad, CA) 
and siPORT neoFX transfection reagent from Applied 
Biosystems (Foster city, CA)
Cell culture
SKOV-3, OVCAR-3 and TOV-21G cells were 
procured from American Type Culture Collection (ATCC, 
Manassas, VA) and maintained as described previously 
[18]. 
Western blotting
SKOV-3, OVCAR-3 and TOV-21G cells were 
exposed to varying concentrations of DIM for 24 
hours. Cells were collected, lysed and 20-80 µg protein 
was subjected to SDS gel electrophoresis followed by 
immunoblotting as previously described by us [18, 36].
Acridine orange assay
SKOV-3, OVCAR-3 or TOV-21G cells were plated 
at a density of 0.3 x 106 cells per well in a six-well 
plate and allowed to attach overnight. Cells were then 
treated with or without DIM.  After 24 hours, cells were 
washed, suspended in binding buffer and incubated for 15 
minutes with 0.1µg/ml acridine orange. Fluorescence was 
measured using C6 Accuri flowcytometer (Ann Arbor, MI) 
with a minimum of 10,000 events per sample. In another 
experiment, cells were treated with 10nM bafilomycin or 
5µM chloroquine prior to the treatment with DIM and 
processed as explained above. 
Transmission electron microscopy
SKOV-3 cells treated with or without DIM were 
harvested  by  trypsinization  and  fixed  in  ice  cold  3% 
glutaraldehyde overnight. 
After washing in PBS, cells were post fixed in Oso4 
and embedded in EPON resin. Embedded samples were 
further processed for ultra-structural analysis as described 
previously [37].
Inhibitors treatment
About 0.3 x 106 SKOV-3, OVCAR-3 or TOV-21G 
cells  were  treated  with  either  10nM  bafilomycin A1, 
100nM mithramycin, 10µg/ml cycloheximide, 5µM 
chloroquine or 5mg/ml compound c for 2 hours before 
treating with 75µM DIM for 24 hours. Only in the case 
where cells were exposed to 10µM BAPT-AM, cells were 
treated with DIM for 4 hours. After the treatment time, 
cells were collected and processed for western blotting as 
explained above. 
Calcium measurement using flowcytometry
Calcium  was  measured  using  flowcytometer  as 
described previously [38] with some modifications. About 
1 x 106 cells were plated in a 100mm tissue culture dish 
and allowed to attach in the incubator overnight. Cells 
were then incubated with Fluo-3AM Dulbecco’s PBS 
without Ca2+ and Mg2+ at 37oC for 15 minutes. A base line 
reading was taken by flowcytometer before addition of 
DIM. After treating cells with DIM for one minute, EGTA 
that chelates calcium was used as a negative control. 
In vivo tumor xenograft
Four to six weeks old female athymic nude mice 
were purchased from Charles River Laboratories 
(Wilmington, MA). The use of mice and their treatment 
was approved by Institutional Animal Care and Use 
Committee (IACUC), Texas Tech University Health 
Sciences Center. All experiments were carried out in 
strict compliance with regulations. Mice were fed with an 
antioxidant-free AIN-76A special diet for a week before 
starting the experiment. About 5 x 106 SKOV-3 cells were 
injected subcutaneously into both right and left flanks. Ten 
mice were assigned randomly to each group. Since each 
mouse was implanted with two xenografts, each group 
had twenty tumors. Two days after tumor implantation, 
mice in the control group received PBS whereas mice in 
the treatment group received 2mg DIM suspended in PBS 
by oral gavage every day. Beginning the 7th day after cell 
implantation, tumor volume was measured thrice a week 
using vernier calipers until day 42 as previously described 
by us [36, 39]. At day 42, mice were euthanized and 
tumors were removed and snap frozen for western blot 
analysis.  
Statistical Analysis
All the statistical analysis was performed using 
Prism 5.0 (GraphPad Software Inc., San Diego, CA). The 
data represents mean values with SEM. Student’s t-test 
were used to compare the control and treated groups. 
In experiments involving more than three groups, non-
parametric analysis of variance followed by Bonferroni 
post hoc multiple comparision test was used. All statistical 
tests were two sided. Differences were considered 
statistically significant when the p value was less than 
0.05.
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